
Hawksbill Pharmaceuticals Private Limited
About Hawksbill Pharmaceuticals Private Limited
Data last updated:
Hawksbill Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2021PTC120020. Its GSTIN is 24AAFCH6465G1ZJ (Gujarat). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹75,000. It is led by directors including Aahna Sinha and Astha Sinha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 401 Lake View Tower Opp. Vastrapur Lake Vastrapur, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹52.1 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹1.6 Lakh (net margin 3.1%) and EBITDA of ₹4.74 Lakh (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.
As per MCA filings, the company has open charges of ₹26 Lakh on record.
Hawksbill Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0063384).
Company details
Recognitions & Rankings of Hawksbill Pharmaceuticals
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-GJ-01-0063384
Contact details
Hawksbill Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 401 Lake View Tower Opp. Vastrapur Lake Vastrapur, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Hawksbill Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hawksbill Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Hawksbill Pharmaceuticals Private Limited, buy the company report.
Financials of Hawksbill Pharmaceuticals Private Limited
FY 2025 filings availableHawksbill Pharmaceuticals Private Limited reported revenue of ₹52.1 Lakh (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over three years, including 9% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.6 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.1% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hawksbill Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hawksbill Pharmaceuticals Private Limited
Hawksbill Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aahna Sinha | Director | 21 Aug 2023 | 3 Years 3 Months | Current |
| Astha Sinha | Director | 21 Aug 2023 | 3 Years 3 Months | Current |
| Bishwas Kumar Sinha | Director | 05 Feb 2021 | 5 Years 9 Months | Current |
Peer comparison
Hawksbill Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fab Biotech Private Limited | ₹52.26 Lakh (FY 2025) | -24.0% | Greater Noida, Uttar Pradesh, India | |||
| Hawksbill Pharmaceuticals Private Limitedthis company | ₹52.1 Lakh (FY 2025) | ₹1.6 Lakh | 3.1% | 9.0% | Ahmedabad, Gujarat, India | |
| Prochem Bioceuticals Private Limited | ₹52.07 Lakh (FY 2025) | -13.0% | Delhi, India | |||
| Myriad Pharmaceuticals Private Limited | ₹52.03 Lakh (FY 2025) | 10.0% | Nagpur, Maharashtra, India | |||
| Bioziv Healthcare Private Limited | ₹51.99 Lakh (FY 2024) | -23.0% | Manimajra, Chandigarh, India |
To see the full peer comparison of Hawksbill Pharmaceuticals Private Limited, buy the company report.
Auditor
Hawksbill Pharmaceuticals Private Limited is audited by Manjot Sachdev & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Manjot Sachdev & Associates | FY 2023 | 029529N |
Shareholding
The shareholding of Hawksbill Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Hawksbill Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Sep 2023 | 100799541 | Indian Overseas Bank | ₹18 Lakh | Open | |
| 31 Mar 2022 | 100565038 | Indian Overseas Bank | ₹8 Lakh | Open |
To see the full charge records of Hawksbill Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Hawksbill Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hawksbill Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Hawksbill Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
GST
Hawksbill Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCH6465G1ZJ | Gujarat | Active | 22 Feb 2021 |
| 05AAFCH6465G1ZJ | Uttarakhand | Active | 18 Apr 2021 |
To see the full GST registrations and return filing status of Hawksbill Pharmaceuticals Private Limited, buy the company report.
Recent activity
Hawksbill Pharmaceuticals Private Limited has 7 board changes on record since 2021: 3 appointments and 4 cessations. The latest: Aahna Sinha ceased to be Additional Director on 29 Sep 2023.
1 earlier event is in the company report.
Frequently asked questions
Hawksbill Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 February 2021 (5+ years old) and is registered under CIN U24230GJ2021PTC120020.
Hawksbill Pharmaceuticals has 3 current directors:
- Aahna Sinha - Director
- Astha Sinha - Director
- Bishwas Kumar Sinha - Director
The latest financial statements of Hawksbill Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Hawksbill Pharmaceuticals is 24AAFCH6465G1ZJ, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AAFCH6465G1ZJ (Uttarakhand).
The CIN (Corporate Identification Number) of Hawksbill Pharmaceuticals is U24230GJ2021PTC120020. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hawksbill Pharmaceuticals was incorporated on 05 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Hawksbill Pharmaceuticals by revenue are Fab Biotech Private Limited, Prochem Bioceuticals Private Limited, Myriad Pharmaceuticals Private Limited, Bioziv Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Aahna Sinha ceased to be Additional Director on 29 Sep 2023. Astha Sinha ceased to be Additional Director on 29 Sep 2023. Subodh Kumar ceased to be Director on 12 Sep 2023. Hawksbill Pharmaceuticals has 7 board changes on record in total.
Yes, Hawksbill Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Hawksbill Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0063384).
The registered office of Hawksbill Pharmaceuticals is at B – 401 Lake View Tower Opp. Vastrapur Lake Vastrapur, Ahmedabad, Gujarat, India – 380015.

